title: Lactobacillus paracasei continuous ambulatory peritoneal dialysis-related peritonitis and review of the literature.
abstract: We describe the first case of continuous ambulatory peritoneal dialysis (CAPD)-related peritonitis due to Lactobacillus paracasei. It occurred in a 65-year-old patient with recurrent episodes of peritonitis while he was receiving a prolonged course of intraperitoneal vancomycin. L. paracasei should be considered in the differential diagnosis of pathogens in CAPD-related peritonitis, especially in patients receiving prolonged vancomycin or glycopeptide treatment.
authors.affiliation: Dayton Veterans Affairs Medical Center, Wright State University School of Medicine, Dayton, Ohio 45428, USA.
authors.forename: Phyllis A
authors.initials: PA
authors.lastname: Neef
authors.forename: Hari
authors.initials: H
authors.lastname: Polenakovik
authors.forename: Jill E
authors.initials: JE
authors.lastname: Clarridge
authors.forename: Mohammad
authors.initials: M
authors.lastname: Saklayen
authors.forename: Laura
authors.initials: L
authors.lastname: Bogard
authors.forename: Jack M
authors.initials: JM
authors.lastname: Bernstein
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D007778:Lactobacillus / Q000302:isolation & purification; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy / Q000382:microbiology*; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin